We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech focused on developing personalized, tumor-targeted immunotherapies. The company is based in Plymouth Meeting, PA. We wanted to share these excerpts from the conversation:
What are the biggest and/or most common challenges you meet with during the
After record attendance and a high energy atmosphere at SCOPE 2020 in Orlando last week, the ArcheMedX team wanted to share our key takeaways:
With an entire track dedicated to Quality & Monitoring it is clear that whether you are focused on your broader risk-based quality management strategy or still zoomed
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical research service provider specializing in patient-focused trial designs, often with at-home visit support. We wanted to share these excerpts from the conversation:
What do you see as the biggest or most common challenges to preparation for,
SCOPE 2020 is almost upon us!
This year, ArcheMedX is helping to shape the conversation on how we, as clinical operations leaders, can improve clinical trial readiness. It is our hope to connect with you and your colleagues in Orlando to spark a conversation that explores operational challenges further and helps
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
Check back regularly for more.
We recently talked with Suzanne Kincaid, Chief Operating Officer at Aperio Clinical Outcomes, a CRO based in the Research Triangle Park area of North Carolina. We wanted to share these excerpts
When I first wrote this blog, I anticipated that 2020 would be a year that we could begin to advance the success of clinical trials for sponsors, CROs, and the patients who ultimately benefit with digital improvements to clinical trial training. Looking back, it's incredible how that idea escalated due
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they are changing, and how they are likely to change. We wanted to share this excerpt from the conversation:
What are your predictions for how clinical operations will work— or should work—in the future?
Over the last year, we’ve been utilizing data analytics more and
We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck, about staffing clinical trial operations as part of our new interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
We wanted to share this excerpt from the conversation with Adam:
When you are working on the
ArcheMedX is heading west January 12th-15th for the 38th Annual JP Morgan Healthcare Conference. Let's connect in San Francisco to explore how behavioral science and actionable insights can improve clinical trial readiness and commercial success.
Please contact our team to coordinate a specific time to meet during the conference and /